A decrease in or absence of MHC-I expression results in tumor immune escape and failure of immunotherapy largely due to a lack of tumor antigen presentation to recruit and activate CD8+ cytotoxic T lymphocytes (2). The gene discussed is CD8A; the disease is neoplasm.